Aluminium compounds for use in vaccines

Abstract

Summary Aluminium adjuvants are the most widely used adjuvants in both human and veterinary vaccines. These adjuvants have been used in practical vaccination for more than 60 years and are generally recognized as safe and as stimulators of Th2 immunity. The present review gives a short introduction to the pioneering research at the start of the use of aluminium compounds as adjuvants, including references on the chemistry of these compounds. Analytical methods for identifying the most commonly used aluminium compounds, such as boehmite and aluminium hydroxyphosphate, are mentioned. Emphasis is placed on the important factors for antigen adsorption and on the latest work using gene-deficient mice in the research of the mechanism of aluminium adjuvants in terms of cytokine and T-cell subset stimulation. Key references on the ability of aluminium adjuvants to stimulate IgE and also in vivo clearing of aluminium adjuvants are discussed. Furthermore, the review addresses the issue of local reactions in the context of injection route and local tissue disturbance. Possible new applications of aluminium adjuvants in, for example, combined aluminium-adsorbed protein and DNA oligonucleotide vaccines as well as the possible use of aluminium adjuvants in combination with IL-12 to stimulate Th1-type immune responses are mentioned.

Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice

“…T-cell response [45][46][47] Recent studies report that in a murine model of acute bacterial infection with S. flexneri the T cell response is dominated by the induction of long-term memory Shigellaspecific Th17 cells that contribute to mediate protective immunity against reinfection [52] Now, new research shows an unexpected direct role for TLR2 signalling in T cells themselves, promoting the differentiation and proliferation of T helper 17 (T H 17) cells [50]. Taking into account these data and together with previous results from our own group about the high ability of PVM/MA to stimulate TLR2 [5] suggest that these …”

A therapeutic nanoparticle vaccine againstTrypanosoma cruziin a BALB/c mouse model of Chagas disease

“…CpG ODNs are potent stimulators of the T H 1-mediated CD8 C T cell immune response. 39,40 In this study, we investigated the immune response elicited by a Tc24 recombinant protein vaccine in mice when delivered in a PLGA nanoparticle delivery system with CpG ODN as an immunomodulatory adjuvant. We also tested the therapeutic efficacy of this vaccine in a mouse model of Chagas disease.…”

The PorB porin from commensal Neisseria lactamica induces Th1 and Th2 immune responses to ovalbumin in mice and is a potential immune adjuvant

“…However, the majority of adjuvants are not accepted for use in humans [2]. Although several potential adjuvants are in experimental stages, the only licensed adjuvant in use for humans in the United States is aluminum and calcium salts [3]. We propose that the PorB porin from commensal N. Lactamica acts as an immune adjuvant and has the potential of being developed as a potent immune modulator derived from a non-pathogenic bacterium, which would positively affect ease of manufacturing.…”